NR 508 ADVANCED PHARM MIDTERM EXAM
Meest recente samenvattingen op de NR 508 ADVANCED PHARM MIDTERM EXAM. Op zoek naar een samenvatting op de NR 508 ADVANCED PHARM MIDTERM EXAM? Wij hebben diverse samenvattingen en notities voor jouw school of universiteit.
-
1
- 0
- 0
All courses for NR 508 ADVANCED PHARM MIDTERM EXAM
-
NR 508 ADVANCED PHARM MIDTERM EXAM 1
Laatste content NR 508 ADVANCED PHARM MIDTERM EXAM
NR 508 ADVANCED PHARM MIDTERM EXAMA patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medication to cholestyramine (Questran). Correct! ...
- Tentamen (uitwerkingen)
- • 27 pagina's's •
-
NR 508 ADVANCED PHARM MIDTERM EXAM•NR 508 ADVANCED PHARM MIDTERM EXAM
Voorbeeld 3 van de 27 pagina's
Document laden...
NR 508 ADVANCED PHARM MIDTERM EXAMA patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medication to cholestyramine (Questran). Correct! ...